Cleveland Clinic is recruiting postmenopausal women for a new Tymlos Patch study. The trial compares Abaloparatide/Tymlos(R) injection vs Tymlos(R) patch.
Romosozumab significantly reduced fracture risk, though close follow-up is required.
The US Food and Drug Administration (FDA) has approved the humanized monoclonal antibody romosozumab (Evenity, Amgen) for treatment of osteoporosis in postmenopausal women with a history of…
Chad Deal, MD • Sabrina K. Sahni, MD • Dr. Anna Camille Moreno